Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartbeam, Inc. - Common Stock (NQ:BEAT)

1.620 -0.030 (-1.82%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,047
Open 1.690
Bid (Size) 1.560 (100)
Ask (Size) 1.780 (200)
Prev. Close 1.650
Today's Range 1.600 - 1.700
52wk Range 0.9101 - 3.480
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HeartBeam Inc. (NASDAQ: BEAT) Advances Toward Commercialization of Groundbreaking ECG System
Via Investor Brand Network
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Initiated With Buy Rating and $4 Price Target by Roth Capital
Via Investor Brand Network

Performance

YTD
-31.1%
-31.1%
1 Month
-8.0%
-8.0%
3 Month
+73.0%
+73.0%
6 Month
-10.5%
-10.5%
1 Year
-35.5%
-35.5%

More News

Read More
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Third Quarter 2025 Conference Call for Nov. 13
Via Investor Brand Network
Topics Intellectual Property
HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Partners with HeartNexus to Deliver 24/7 Remote Cardiology Services and Real-Time ECG Interpretation
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere
From HeartBeam, Inc.
Via Business Wire
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Combining Portability and Precision to Redefine Future of Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) on the Beat of Cardiac Innovation
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Validates ECG Technology with Strong Results in Pivotal Study
Via Investor Brand Network
Topics Artificial Intelligence
NetworkNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) ECG System Offers Real-Time Cardiac Insights
Via Investor Brand Network
Topics Credit Cards Intellectual Property
BioMedNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) First-of-Its-Kind Cable-Free ECG Offers Multi-Angle Signal Capture
Via Investor Brand Network
Topics Intellectual Property
HeartBeam Inc. (NASDAQ: BEAT) Prepares Innovative ECG Technology for Commercial Launch
Via Investor Brand Network
HeartBeam Inc. (NASDAQ: BEAT) Advances Power of ECG with High-Fidelity At-Home Heart-Monitoring System
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Study Showing Comparable Accuracy Between HeartBeam System and Standard 12-Lead ECG in Detecting Arrhythmias
Via Investor Brand Network
Topics Intellectual Property
HeartBeam’s Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Profiled on Credit-Card-Sized Device That Synthesizes 12-Lead ECG
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) to Present at Three September Investor Conferences
Via Investor Brand Network
Topics Intellectual Property
HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025
From HeartBeam, Inc.
Via Business Wire
HeartBeam Inc. (NASDAQ: BEAT) Advances Patient Convenience with At-Home ECG Technology
Via Investor Brand Network
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Paves Way to Redefine Cardiac Care
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks — HeartBeam Inc.’s (NASDAQ: BEAT) IP Momentum Continues with New Patents Advancing 3D ECG Technology
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Q2 2025 Results, Advances Toward FDA Clearance and Commercial Launch
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
HeartBeam Cuts Costs Awaits FDA Decision
Via The Motley Fool
HeartBeam (BEAT) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Artificial Intelligence Earnings
HeartBeam Inc (NASDAQ:BEAT) Reports Q2 2025 Results: Narrower Loss, FDA Progress, and Mixed Market Reaction
Via Chartmill

Frequently Asked Questions

Is Heartbeam, Inc. - Common Stock publicly traded?
Yes, Heartbeam, Inc. - Common Stock is publicly traded.
What exchange does Heartbeam, Inc. - Common Stock trade on?
Heartbeam, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Heartbeam, Inc. - Common Stock?
The ticker symbol for Heartbeam, Inc. - Common Stock is BEAT on the Nasdaq Stock Market
What is the current price of Heartbeam, Inc. - Common Stock?
The current price of Heartbeam, Inc. - Common Stock is 1.620
When was Heartbeam, Inc. - Common Stock last traded?
The last trade of Heartbeam, Inc. - Common Stock was at 11/06/25 04:00 PM ET
What is the market capitalization of Heartbeam, Inc. - Common Stock?
The market capitalization of Heartbeam, Inc. - Common Stock is 55.50M
How many shares of Heartbeam, Inc. - Common Stock are outstanding?
Heartbeam, Inc. - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.